Christopher Gignoux
Concepts (360)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetics, Population | 30 | 2023 | 207 | 3.340 |
Why?
| Genome, Human | 24 | 2023 | 387 | 2.120 |
Why?
| Genome-Wide Association Study | 33 | 2023 | 1323 | 1.990 |
Why?
| Polymorphism, Single Nucleotide | 46 | 2023 | 2062 | 1.870 |
Why?
| Genetic Variation | 17 | 2022 | 926 | 1.730 |
Why?
| Genomics | 18 | 2024 | 706 | 1.340 |
Why?
| Genetic Predisposition to Disease | 22 | 2023 | 2275 | 1.330 |
Why?
| Models, Genetic | 11 | 2022 | 595 | 1.100 |
Why?
| Asthma | 19 | 2019 | 2157 | 1.100 |
Why?
| Genetics, Medical | 5 | 2023 | 26 | 1.010 |
Why?
| Precision Medicine | 3 | 2024 | 363 | 0.930 |
Why?
| Pharmacogenetics | 2 | 2021 | 151 | 0.880 |
Why?
| Biological Specimen Banks | 5 | 2024 | 104 | 0.870 |
Why?
| Gastritis | 1 | 2023 | 82 | 0.850 |
Why?
| Enteritis | 1 | 2023 | 78 | 0.840 |
Why?
| Desogestrel | 1 | 2021 | 41 | 0.780 |
Why?
| Transcriptome | 4 | 2023 | 756 | 0.730 |
Why?
| Haplotypes | 20 | 2022 | 473 | 0.720 |
Why?
| Human Migration | 6 | 2021 | 21 | 0.710 |
Why?
| Gene Flow | 8 | 2020 | 79 | 0.670 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 2018 | 12 | 0.670 |
Why?
| Smad2 Protein | 1 | 2018 | 39 | 0.660 |
Why?
| Eosinophilic Esophagitis | 1 | 2023 | 308 | 0.660 |
Why?
| Humans | 115 | 2024 | 118969 | 0.610 |
Why?
| Genotype | 23 | 2022 | 1882 | 0.590 |
Why?
| Gene Frequency | 12 | 2023 | 513 | 0.580 |
Why?
| Multifactorial Inheritance | 6 | 2023 | 143 | 0.550 |
Why?
| Chromosome Mapping | 11 | 2023 | 510 | 0.540 |
Why?
| Population | 2 | 2014 | 30 | 0.520 |
Why?
| DNA, Mitochondrial | 6 | 2016 | 187 | 0.510 |
Why?
| Population Growth | 2 | 2012 | 10 | 0.510 |
Why?
| Metagenomics | 4 | 2023 | 134 | 0.510 |
Why?
| Indians, North American | 7 | 2021 | 598 | 0.480 |
Why?
| Receptors, KIR | 5 | 2022 | 89 | 0.470 |
Why?
| Mexican Americans | 7 | 2023 | 100 | 0.460 |
Why?
| Agriculture | 2 | 2011 | 90 | 0.450 |
Why?
| Genetic Loci | 7 | 2019 | 281 | 0.410 |
Why?
| Exome | 5 | 2022 | 220 | 0.410 |
Why?
| Evolution, Molecular | 5 | 2021 | 454 | 0.410 |
Why?
| Molecular Epidemiology | 3 | 2023 | 69 | 0.380 |
Why?
| Indians, South American | 2 | 2020 | 23 | 0.380 |
Why?
| Pedigree | 3 | 2021 | 485 | 0.370 |
Why?
| Genetic Association Studies | 3 | 2022 | 371 | 0.350 |
Why?
| Population Groups | 2 | 2020 | 58 | 0.350 |
Why?
| Linkage Disequilibrium | 9 | 2023 | 273 | 0.340 |
Why?
| Quantitative Trait Loci | 5 | 2023 | 324 | 0.330 |
Why?
| Alleles | 10 | 2022 | 832 | 0.320 |
Why?
| Skin Pigmentation | 2 | 2018 | 43 | 0.320 |
Why?
| Phenotype | 12 | 2023 | 3003 | 0.320 |
Why?
| Selection, Genetic | 4 | 2019 | 252 | 0.310 |
Why?
| Receptors, KIR2DL1 | 2 | 2018 | 17 | 0.300 |
Why?
| Environmental Exposure | 3 | 2017 | 405 | 0.290 |
Why?
| Mexico | 8 | 2023 | 165 | 0.290 |
Why?
| Gene-Environment Interaction | 3 | 2023 | 201 | 0.290 |
Why?
| Genetic Markers | 7 | 2023 | 348 | 0.290 |
Why?
| Phylogeography | 5 | 2020 | 45 | 0.280 |
Why?
| Colorado | 4 | 2024 | 4196 | 0.280 |
Why?
| Female | 42 | 2022 | 61564 | 0.280 |
Why?
| Minority Groups | 2 | 2019 | 237 | 0.270 |
Why?
| Delivery of Health Care | 2 | 2023 | 867 | 0.260 |
Why?
| Phylogeny | 7 | 2022 | 816 | 0.260 |
Why?
| Killer Cells, Natural | 4 | 2021 | 381 | 0.250 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1597 | 0.250 |
Why?
| Puerto Rico | 8 | 2021 | 56 | 0.250 |
Why?
| Heterozygote | 3 | 2021 | 262 | 0.240 |
Why?
| Young Adult | 12 | 2022 | 10793 | 0.240 |
Why?
| Chromosomes, Human, Pair 6 | 3 | 2014 | 47 | 0.240 |
Why?
| Genes, MHC Class I | 2 | 2021 | 33 | 0.240 |
Why?
| Thyroid Nodule | 1 | 2024 | 38 | 0.230 |
Why?
| Algorithms | 3 | 2023 | 1541 | 0.220 |
Why?
| Male | 39 | 2023 | 57800 | 0.220 |
Why?
| Receptors, KIR3DS1 | 1 | 2022 | 6 | 0.210 |
Why?
| Proteins | 2 | 2022 | 938 | 0.210 |
Why?
| Receptors, KIR3DL1 | 1 | 2022 | 15 | 0.210 |
Why?
| Emigration and Immigration | 3 | 2013 | 47 | 0.210 |
Why?
| Immunoglobulin E | 2 | 2014 | 365 | 0.210 |
Why?
| Collagen Type VII | 1 | 2021 | 13 | 0.210 |
Why?
| Jews | 1 | 2021 | 19 | 0.200 |
Why?
| Risk Factors | 14 | 2023 | 8999 | 0.200 |
Why?
| Myocardial Ischemia | 1 | 2023 | 251 | 0.200 |
Why?
| Demography | 5 | 2018 | 274 | 0.200 |
Why?
| Epidermolysis Bullosa Dystrophica | 1 | 2021 | 21 | 0.200 |
Why?
| Pharmacogenomic Variants | 1 | 2021 | 35 | 0.200 |
Why?
| History, Medieval | 3 | 2021 | 43 | 0.200 |
Why?
| Uterine Hemorrhage | 1 | 2021 | 36 | 0.200 |
Why?
| Adolescent | 18 | 2021 | 18479 | 0.200 |
Why?
| Drug Implants | 1 | 2021 | 72 | 0.200 |
Why?
| Computational Biology | 2 | 2023 | 588 | 0.200 |
Why?
| Islands | 1 | 2020 | 5 | 0.190 |
Why?
| Indians, Central American | 1 | 2020 | 7 | 0.190 |
Why?
| Latin America | 2 | 2018 | 74 | 0.190 |
Why?
| Thyroid Neoplasms | 1 | 2024 | 278 | 0.190 |
Why?
| Population Health | 1 | 2021 | 46 | 0.190 |
Why?
| Self Report | 2 | 2021 | 699 | 0.190 |
Why?
| Reference Standards | 1 | 2020 | 176 | 0.180 |
Why?
| Adaptation, Biological | 1 | 2020 | 57 | 0.180 |
Why?
| Pre-Eclampsia | 1 | 2022 | 183 | 0.180 |
Why?
| Lipase | 1 | 2020 | 70 | 0.180 |
Why?
| Case-Control Studies | 9 | 2022 | 3171 | 0.180 |
Why?
| Human Genetics | 1 | 2019 | 4 | 0.170 |
Why?
| Inflammatory Bowel Diseases | 1 | 2023 | 290 | 0.170 |
Why?
| Data Interpretation, Statistical | 1 | 2021 | 336 | 0.170 |
Why?
| Triglycerides | 2 | 2023 | 519 | 0.170 |
Why?
| Apolipoprotein L1 | 1 | 2018 | 15 | 0.170 |
Why?
| Geographic Mapping | 1 | 2019 | 21 | 0.170 |
Why?
| Antiporters | 1 | 2018 | 16 | 0.170 |
Why?
| Liver Diseases | 1 | 2021 | 282 | 0.170 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2017 | 770 | 0.170 |
Why?
| Europe | 5 | 2020 | 356 | 0.170 |
Why?
| Coronary Artery Disease | 2 | 2023 | 647 | 0.170 |
Why?
| Obesity | 2 | 2023 | 2746 | 0.160 |
Why?
| Proteome | 1 | 2022 | 353 | 0.160 |
Why?
| Feasibility Studies | 1 | 2021 | 749 | 0.160 |
Why?
| United States | 15 | 2021 | 12554 | 0.160 |
Why?
| Chromosomes, Human, Y | 2 | 2008 | 15 | 0.160 |
Why?
| Atherosclerosis | 1 | 2022 | 345 | 0.160 |
Why?
| HLA-C Antigens | 1 | 2018 | 32 | 0.160 |
Why?
| Primates | 1 | 2019 | 114 | 0.160 |
Why?
| Microbiota | 2 | 2023 | 656 | 0.160 |
Why?
| Fibrillar Collagens | 1 | 2017 | 12 | 0.160 |
Why?
| Collagen Diseases | 1 | 2017 | 6 | 0.160 |
Why?
| Weight Gain | 1 | 2021 | 493 | 0.150 |
Why?
| Saliva | 2 | 2020 | 188 | 0.150 |
Why?
| Patient Acceptance of Health Care | 1 | 2023 | 687 | 0.150 |
Why?
| Apolipoprotein A-V | 1 | 2017 | 3 | 0.150 |
Why?
| Dermatitis, Atopic | 1 | 2021 | 332 | 0.150 |
Why?
| Epistasis, Genetic | 1 | 2017 | 73 | 0.150 |
Why?
| Computer Simulation | 5 | 2022 | 922 | 0.150 |
Why?
| Gene Pool | 2 | 2013 | 5 | 0.150 |
Why?
| History, Ancient | 3 | 2013 | 58 | 0.150 |
Why?
| Women's Health | 1 | 2019 | 274 | 0.150 |
Why?
| Colorectal Neoplasms | 1 | 2023 | 628 | 0.140 |
Why?
| Language | 2 | 2011 | 271 | 0.140 |
Why?
| Adult | 15 | 2021 | 31510 | 0.140 |
Why?
| Homozygote | 3 | 2023 | 190 | 0.140 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 280 | 0.140 |
Why?
| Aged | 9 | 2023 | 19656 | 0.140 |
Why?
| Research Design | 1 | 2022 | 969 | 0.140 |
Why?
| DNA Methylation | 2 | 2017 | 503 | 0.140 |
Why?
| Colombia | 3 | 2021 | 43 | 0.130 |
Why?
| Social Class | 2 | 2013 | 218 | 0.130 |
Why?
| Kidney Diseases | 1 | 2018 | 439 | 0.120 |
Why?
| Premature Birth | 1 | 2018 | 284 | 0.120 |
Why?
| Genealogy and Heraldry | 1 | 2013 | 5 | 0.120 |
Why?
| Health Surveys | 1 | 2016 | 454 | 0.120 |
Why?
| Africa, Southern | 3 | 2018 | 8 | 0.120 |
Why?
| Ikaros Transcription Factor | 1 | 2014 | 17 | 0.120 |
Why?
| Minority Health | 1 | 2013 | 20 | 0.120 |
Why?
| Emigrants and Immigrants | 1 | 2016 | 115 | 0.120 |
Why?
| Pandemics | 1 | 2022 | 1354 | 0.120 |
Why?
| RNA-Binding Proteins | 1 | 2017 | 371 | 0.120 |
Why?
| Population Dynamics | 2 | 2012 | 137 | 0.120 |
Why?
| Child | 15 | 2020 | 19129 | 0.120 |
Why?
| Urban Health | 1 | 2013 | 78 | 0.120 |
Why?
| Membrane Proteins | 1 | 2020 | 1055 | 0.120 |
Why?
| Search Engine | 1 | 2013 | 15 | 0.120 |
Why?
| Air Pollution | 1 | 2016 | 209 | 0.120 |
Why?
| Kv Channel-Interacting Proteins | 1 | 2013 | 4 | 0.110 |
Why?
| Nasal Mucosa | 1 | 2014 | 97 | 0.110 |
Why?
| Albuterol | 1 | 2013 | 104 | 0.110 |
Why?
| Neanderthals | 1 | 2013 | 11 | 0.110 |
Why?
| Hypersensitivity, Immediate | 1 | 2013 | 59 | 0.110 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 2012 | 25 | 0.110 |
Why?
| Principal Component Analysis | 1 | 2013 | 180 | 0.110 |
Why?
| Kallikreins | 1 | 2012 | 33 | 0.110 |
Why?
| Carrier Proteins | 1 | 2017 | 726 | 0.110 |
Why?
| HLA-DQ beta-Chains | 1 | 2012 | 61 | 0.110 |
Why?
| Forced Expiratory Volume | 2 | 2013 | 520 | 0.110 |
Why?
| Respiratory Function Tests | 2 | 2012 | 526 | 0.110 |
Why?
| Biological Evolution | 2 | 2019 | 443 | 0.100 |
Why?
| United Kingdom | 2 | 2023 | 236 | 0.100 |
Why?
| Prostate-Specific Antigen | 1 | 2012 | 156 | 0.100 |
Why?
| Tuberculosis | 1 | 2014 | 240 | 0.100 |
Why?
| Mycobacterium tuberculosis | 1 | 2014 | 266 | 0.100 |
Why?
| Cross-Sectional Studies | 1 | 2022 | 4552 | 0.100 |
Why?
| Bronchodilator Agents | 1 | 2013 | 253 | 0.100 |
Why?
| Lung | 2 | 2016 | 3664 | 0.100 |
Why?
| HLA-B Antigens | 2 | 2022 | 55 | 0.100 |
Why?
| History, 15th Century | 1 | 2011 | 12 | 0.100 |
Why?
| History, 17th Century | 1 | 2011 | 18 | 0.100 |
Why?
| Polynesia | 2 | 2021 | 4 | 0.100 |
Why?
| History, 18th Century | 1 | 2011 | 23 | 0.100 |
Why?
| Breast Neoplasms | 2 | 2014 | 1965 | 0.100 |
Why?
| History, 19th Century | 1 | 2011 | 61 | 0.100 |
Why?
| Chile | 2 | 2021 | 16 | 0.100 |
Why?
| Cluster Analysis | 3 | 2023 | 481 | 0.100 |
Why?
| Respiratory Sounds | 1 | 2011 | 119 | 0.100 |
Why?
| Estrogen Receptor alpha | 1 | 2012 | 126 | 0.100 |
Why?
| Body Height | 2 | 2023 | 187 | 0.100 |
Why?
| History, 21st Century | 1 | 2011 | 170 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2022 | 1798 | 0.090 |
Why?
| South Africa | 3 | 2015 | 163 | 0.090 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 290 | 0.090 |
Why?
| History, 20th Century | 1 | 2011 | 281 | 0.090 |
Why?
| Electronic Health Records | 3 | 2021 | 829 | 0.090 |
Why?
| Genotyping Techniques | 2 | 2020 | 75 | 0.090 |
Why?
| Databases, Genetic | 2 | 2021 | 253 | 0.090 |
Why?
| Vital Capacity | 1 | 2010 | 260 | 0.090 |
Why?
| Peru | 2 | 2022 | 59 | 0.090 |
Why?
| Mutation | 4 | 2018 | 3457 | 0.090 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2023 | 2174 | 0.090 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1167 | 0.080 |
Why?
| Chromosomes, Human, Pair 8 | 2 | 2019 | 32 | 0.080 |
Why?
| Africa | 3 | 2017 | 100 | 0.080 |
Why?
| South America | 2 | 2020 | 56 | 0.080 |
Why?
| Life Style | 2 | 2022 | 430 | 0.080 |
Why?
| Americas | 2 | 2018 | 23 | 0.080 |
Why?
| Signal Transduction | 2 | 2019 | 4709 | 0.080 |
Why?
| Ants | 1 | 2007 | 27 | 0.080 |
Why?
| Whole Genome Sequencing | 2 | 2018 | 113 | 0.080 |
Why?
| Risk | 3 | 2018 | 853 | 0.080 |
Why?
| Linguistics | 1 | 2007 | 26 | 0.080 |
Why?
| Middle Aged | 9 | 2020 | 27617 | 0.080 |
Why?
| Odds Ratio | 3 | 2014 | 996 | 0.070 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 1136 | 0.070 |
Why?
| Chromosomes, Human, Pair 17 | 2 | 2019 | 63 | 0.070 |
Why?
| Speech | 1 | 2007 | 76 | 0.070 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2022 | 3360 | 0.070 |
Why?
| Human Genome Project | 2 | 2017 | 16 | 0.070 |
Why?
| Epigenesis, Genetic | 2 | 2022 | 539 | 0.070 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 453 | 0.070 |
Why?
| Lung Diseases | 1 | 2012 | 718 | 0.070 |
Why?
| Child, Preschool | 6 | 2020 | 9491 | 0.070 |
Why?
| RNA | 1 | 2011 | 833 | 0.070 |
Why?
| Bias | 2 | 2019 | 198 | 0.070 |
Why?
| Base Sequence | 3 | 2016 | 2159 | 0.060 |
Why?
| Microsatellite Repeats | 3 | 2011 | 143 | 0.060 |
Why?
| Argentina | 2 | 2015 | 14 | 0.060 |
Why?
| Cohort Studies | 4 | 2019 | 5115 | 0.060 |
Why?
| Body Mass Index | 2 | 2023 | 2092 | 0.060 |
Why?
| Iran | 1 | 2023 | 37 | 0.060 |
Why?
| Los Angeles | 1 | 2023 | 60 | 0.060 |
Why?
| Geography | 2 | 2016 | 190 | 0.060 |
Why?
| Polymorphism, Genetic | 2 | 2018 | 642 | 0.060 |
Why?
| Lipoprotein(a) | 1 | 2023 | 49 | 0.060 |
Why?
| Caribbean Region | 2 | 2013 | 24 | 0.060 |
Why?
| Factor X | 1 | 2022 | 25 | 0.050 |
Why?
| Factor VII | 1 | 2022 | 24 | 0.050 |
Why?
| Age Factors | 2 | 2020 | 2995 | 0.050 |
Why?
| Blood Coagulation Factors | 1 | 2022 | 43 | 0.050 |
Why?
| Genome, Viral | 1 | 2022 | 124 | 0.050 |
Why?
| Epigenomics | 1 | 2022 | 107 | 0.050 |
Why?
| Infant, Newborn | 3 | 2020 | 5255 | 0.050 |
Why?
| Genes, Recessive | 1 | 2021 | 73 | 0.050 |
Why?
| HLA-A Antigens | 1 | 2021 | 50 | 0.050 |
Why?
| Inheritance Patterns | 1 | 2021 | 49 | 0.050 |
Why?
| Loss of Function Mutation | 1 | 2021 | 42 | 0.050 |
Why?
| Bronchi | 2 | 2014 | 242 | 0.050 |
Why?
| Quality Control | 1 | 2021 | 159 | 0.050 |
Why?
| China | 1 | 2021 | 175 | 0.050 |
Why?
| Central America | 1 | 2020 | 27 | 0.050 |
Why?
| Infant | 3 | 2021 | 8293 | 0.050 |
Why?
| Blood Proteins | 1 | 2022 | 248 | 0.050 |
Why?
| Longitudinal Studies | 2 | 2020 | 2513 | 0.040 |
Why?
| Ultrasonography | 1 | 2024 | 716 | 0.040 |
Why?
| Aged, 80 and over | 3 | 2020 | 6561 | 0.040 |
Why?
| Chromosomes, Human, Pair 12 | 1 | 2019 | 28 | 0.040 |
Why?
| Topography, Medical | 1 | 2019 | 11 | 0.040 |
Why?
| Asia, Northern | 1 | 2018 | 1 | 0.040 |
Why?
| Mongolia | 1 | 2018 | 2 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2024 | 1795 | 0.040 |
Why?
| Classification | 1 | 2019 | 27 | 0.040 |
Why?
| Databases, Nucleic Acid | 1 | 2018 | 36 | 0.040 |
Why?
| Pharmacogenomic Testing | 1 | 2019 | 54 | 0.040 |
Why?
| Receptors, Natural Killer Cell | 1 | 2018 | 16 | 0.040 |
Why?
| Neoplasm Recurrence, Local | 1 | 2024 | 900 | 0.040 |
Why?
| Health Equity | 1 | 2019 | 56 | 0.040 |
Why?
| Altitude | 1 | 2022 | 422 | 0.040 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2019 | 138 | 0.040 |
Why?
| Hominidae | 1 | 2019 | 99 | 0.040 |
Why?
| Reproducibility of Results | 2 | 2018 | 2874 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2019 | 522 | 0.040 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2018 | 74 | 0.040 |
Why?
| New York City | 1 | 2017 | 75 | 0.040 |
Why?
| Kaplan-Meier Estimate | 1 | 2020 | 842 | 0.040 |
Why?
| Pilot Projects | 1 | 2022 | 1419 | 0.040 |
Why?
| Prospective Studies | 3 | 2014 | 6471 | 0.040 |
Why?
| Health Status Disparities | 1 | 2019 | 209 | 0.040 |
Why?
| Residence Characteristics | 1 | 2019 | 299 | 0.040 |
Why?
| Multigene Family | 1 | 2017 | 200 | 0.040 |
Why?
| DNA, Intergenic | 1 | 2016 | 25 | 0.040 |
Why?
| Software | 1 | 2021 | 613 | 0.040 |
Why?
| Genetic Heterogeneity | 1 | 2016 | 56 | 0.040 |
Why?
| Musculoskeletal Diseases | 1 | 2017 | 68 | 0.040 |
Why?
| Sexism | 1 | 2016 | 45 | 0.030 |
Why?
| Anthropometry | 1 | 2016 | 194 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 2014 | 2871 | 0.030 |
Why?
| Ligands | 1 | 2018 | 567 | 0.030 |
Why?
| Placenta | 1 | 2022 | 639 | 0.030 |
Why?
| Membrane Transport Proteins | 1 | 2017 | 137 | 0.030 |
Why?
| Genetic Testing | 1 | 2018 | 389 | 0.030 |
Why?
| Protein Conformation | 1 | 2019 | 848 | 0.030 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 2014 | 17 | 0.030 |
Why?
| HLA-DQ alpha-Chains | 1 | 2014 | 17 | 0.030 |
Why?
| Crosses, Genetic | 1 | 2014 | 138 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2019 | 2071 | 0.030 |
Why?
| Blood Glucose | 1 | 2023 | 1939 | 0.030 |
Why?
| Animals | 5 | 2019 | 33381 | 0.030 |
Why?
| Mouth | 1 | 2014 | 74 | 0.030 |
Why?
| San Francisco | 1 | 2013 | 57 | 0.030 |
Why?
| Databases, Factual | 1 | 2019 | 1231 | 0.030 |
Why?
| Mammography | 1 | 2014 | 126 | 0.030 |
Why?
| HapMap Project | 1 | 2013 | 3 | 0.030 |
Why?
| HeLa Cells | 1 | 2015 | 583 | 0.030 |
Why?
| Sex Factors | 1 | 2019 | 1781 | 0.030 |
Why?
| Models, Molecular | 1 | 2019 | 1435 | 0.030 |
Why?
| Africa, Northern | 1 | 2013 | 4 | 0.030 |
Why?
| Interleukin-13 | 1 | 2014 | 135 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2014 | 462 | 0.030 |
Why?
| Protein Binding | 1 | 2019 | 1975 | 0.030 |
Why?
| Skin Tests | 1 | 2013 | 135 | 0.030 |
Why?
| Hawaii | 1 | 2012 | 36 | 0.030 |
Why?
| Th2 Cells | 1 | 2014 | 164 | 0.030 |
Why?
| HLA Antigens | 1 | 2014 | 230 | 0.030 |
Why?
| Genome, Mitochondrial | 1 | 2012 | 26 | 0.030 |
Why?
| Income | 1 | 2013 | 173 | 0.030 |
Why?
| Air Pollutants | 1 | 2016 | 316 | 0.030 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2012 | 66 | 0.030 |
Why?
| Meta-Analysis as Topic | 1 | 2012 | 164 | 0.030 |
Why?
| Markov Chains | 1 | 2012 | 118 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 2014 | 387 | 0.030 |
Why?
| Insurance, Health | 1 | 2013 | 244 | 0.030 |
Why?
| Boston | 1 | 2011 | 76 | 0.030 |
Why?
| Canada | 1 | 2012 | 340 | 0.030 |
Why?
| DNA Mutational Analysis | 1 | 2012 | 381 | 0.030 |
Why?
| Mitochondrial Proton-Translocating ATPases | 1 | 2011 | 18 | 0.030 |
Why?
| Educational Status | 1 | 2013 | 437 | 0.030 |
Why?
| Angola | 1 | 2011 | 1 | 0.020 |
Why?
| Mozambique | 1 | 2011 | 5 | 0.020 |
Why?
| Africa South of the Sahara | 1 | 2011 | 37 | 0.020 |
Why?
| Microfilament Proteins | 1 | 2012 | 134 | 0.020 |
Why?
| Bayes Theorem | 1 | 2012 | 344 | 0.020 |
Why?
| North America | 1 | 2011 | 266 | 0.020 |
Why?
| Pregnancy | 1 | 2022 | 5691 | 0.020 |
Why?
| Culture | 1 | 2011 | 129 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2011 | 174 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2011 | 403 | 0.020 |
Why?
| Statistics as Topic | 1 | 2011 | 307 | 0.020 |
Why?
| Allergens | 1 | 2013 | 424 | 0.020 |
Why?
| Time Factors | 1 | 2020 | 6412 | 0.020 |
Why?
| Family | 1 | 2013 | 585 | 0.020 |
Why?
| Reference Values | 1 | 2010 | 774 | 0.020 |
Why?
| Tanzania | 1 | 2008 | 45 | 0.020 |
Why?
| Logistic Models | 1 | 2013 | 1901 | 0.020 |
Why?
| Social Behavior | 1 | 2011 | 276 | 0.020 |
Why?
| Biomarkers, Tumor | 1 | 2014 | 1059 | 0.020 |
Why?
| Inbreeding | 1 | 2007 | 16 | 0.020 |
Why?
| Hypersensitivity | 1 | 2011 | 268 | 0.020 |
Why?
| Linear Models | 1 | 2010 | 827 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 2014 | 1346 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2014 | 2851 | 0.020 |
Why?
| Prevalence | 1 | 2013 | 2326 | 0.020 |
Why?
| Transcription Factors | 1 | 2014 | 1570 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2008 | 490 | 0.020 |
Why?
| Reproduction | 1 | 2007 | 189 | 0.020 |
Why?
| Models, Biological | 1 | 2013 | 1715 | 0.020 |
Why?
| Smoking | 1 | 2012 | 1487 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2011 | 2674 | 0.010 |
Why?
| Surveys and Questionnaires | 1 | 2013 | 4708 | 0.010 |
Why?
| Mice | 1 | 2013 | 15520 | 0.010 |
Why?
|
|
Gignoux's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|